Benzinga Bulls And Bears: Nvidia, Palantir, Marvell Technology — And Markets Rallied In May

U.S. stocks experienced a strong rally in May, with the S&P 500 rising 6.2% and the Nasdaq surging 9.6%, driven by robust tech earnings, particularly from Nvidia which climbed 24%. While analysts anticipate a broader market rally, potential headwinds remain, including the uncertainty surrounding tariffs, as highlighted by a court ruling against President Trump's recent tariffs that has since been appealed. Recent reports indicate bullish sentiment for Palantir, Nvidia, and Ulta Beauty, while Marvell Technology, Regeneron/Sanofi, and gold ETFs faced bearish pressures.

Analysis

U.S. equity markets experienced a significant rally in May, marking the strongest monthly performance since November 2023, with the S&P 500 advancing 6.2% and the Nasdaq Composite surging 9.6%, returning both to positive territory for the year. This rally was largely propelled by robust earnings in the technology sector, exemplified by Nvidia (NVDA), whose stock climbed 24% following a reported 70% year-over-year revenue increase and strong demand for its Blackwell AI chips, leading analysts to project a potential market capitalization of up to $5 trillion. Beyond the dominant "Magnificent Seven," there is an anticipation of a broadening market rally, with expectations for the earnings growth gap between these tech giants and the rest of the S&P 500 to diminish in 2025, supported by improving earnings in industrials, consumer staples, and financials. However, significant uncertainties persist, notably the legal challenge to U.S. tariffs; an appeal is underway, and analysts caution that renewed tariffs, especially on chips and pharmaceuticals, could jeopardize recent market gains. Specific company highlights include bullish sentiment for Palantir (PLTR), with Wedbush analyst Dan Ives forecasting a rise above $400 per share and a $1 trillion market cap, and Ulta Beauty (ULTA), which saw its shares surge over 11% after exceeding Q1 expectations with $6.70 EPS and $2.85 billion in sales, and subsequently raising its fiscal 2025 outlook. Conversely, Marvell Technology (MRVL) shares declined over 3% despite Q1 adjusted EPS of 62 cents on $1.9 billion revenue (both slightly above estimates) and a raised Q2 revenue forecast, indicating muted investor enthusiasm. Regeneron (REGN) and Sanofi (SNY) faced setbacks as their experimental COPD drug, itepekimab, yielded uneven Phase 3 trial results. The SPDR Gold Shares ETF (GLD) experienced significant outflows of $2.1 billion in May, its largest since July 2022, as risk appetite increased, although Goldman Sachs maintains a year-end gold price forecast of $3,700 per ounce.

Key Decisions for Investors

• Investors should consider maintaining exposure to leading AI-focused technology stocks like Nvidia and Palantir, given their strong performance and positive analyst outlooks, but remain cognizant of high valuations and sector concentration risk.
• Monitor developments regarding U.S. tariff policies closely, as renewed or expanded tariffs could introduce significant volatility and negatively impact market sentiment, particularly in the technology and pharmaceutical sectors.
• Evaluate opportunities in sectors beyond technology, such as industrials and consumer staples, in anticipation of a potential broadening of the market rally and narrowing earnings growth differentials in 2025, while exercising caution with companies showing mixed fundamental signals like Marvell or those facing clinical trial uncertainties like Regeneron and Sanofi.
• Reassess allocations to safe-haven assets like gold, as demonstrated by outflows from GLD, but acknowledge long-term bullish arguments for the metal driven by central bank demand and macroeconomic risks, suggesting a tactical rather than wholesale abandonment might be prudent.